Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

ADVM Adverum Biotechnologies

0.950
+0.001+0.11%
Close 09/30 16:00 ET
1.000
+0.050+5.26%
Post Mkt Price 09/30 19:59 ET
High
1.030
Open
1.030
Turnover
312.49K
Low
0.946
Pre Close
0.949
Volume
311.43K
Market Cap
94.37M
P/E(TTM)
Loss
52wk High
2.520
Shares
99.33M
P/E(Static)
Loss
52wk Low
0.795
Float Cap
81.10M
Bid/Ask %
-41.18%
Historical High
62.480
Shs Float
85.37M
Volume Ratio
0.33
Historical Low
0.795
Dividend TTM
--
Div Yield TTM
--
P/B
0.39
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.37%
Amplitude
8.81%
Avg Price
1.003
Lot Size
1
Float Cap
81.10M
Bid/Ask %
-41.18%
Historical High
62.480
Shs Float
85.37M
Volume Ratio
0.33
Historical Low
0.795
Dividend TTM
--
P/B
0.39
Dividend LFY
--
Turnover Ratio
0.37%
Amplitude
8.81%
Avg Price
1.003
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company that engages in the development of gene therapies for ocular and rare diseases. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr., Mitchell H. Finer, and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Redwood City, CA.
CEO: Dr. Laurent Fischer, M.D.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...